XENON PHARMACEUTICALS INC. Adjustments to Additional Paid in Capital, Other
XENON PHARMACEUTICALS INC. (XENE) reported Adjustments to Additional Paid in Capital, Other of $73.00 thousand for the 12-month period ending 2013-12-31, per its 10-K filed 2016-03-08.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2016-03-08
- XENON PHARMACEUTICALS INC. adjustments to additional paid in capital, other for fiscal 2013 was $73.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 12 month |
|---|---|
| 2013-12-31 | $73.00K 10-K · filed 2016-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 |